Weeks after penning a $110 million upfront deal with Orano Med for the global rights to a neuroendocrine tumor treatment, ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...

Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...

Clinical data company Clario and AI firm PathAI are teaming up to create an end-to-end imaging and pathology workflow for ...

TORONTO—NYU Langone Health has tapped Philips to help take its pathology program fully digital—including translating its ...

Takeda is walking away from the last target in a collaboration with Wave Life Scien | Takeda has brandished a termination ...

Johnson & Johnson has burnished the evidence for nipocalimab, adding a sliver of data in adolescents with generalized ...

Eli Lilly is expanding its innovation digs to Beijing, opening two research centers called the Eli Lilly China Medical ...

Sanofi is putting down $18 million across three historically Black medical schools as part of the French pharma's efforts to ...

Lilly already operates two Gateway Labs sites in South San Francisco, as well as cutting the ribbon at a new location at the ...

As it transitions from a discovery- to a clinical-stage biotech, Volastra Therapeutics is bringing longtime adviser Samuel ...